Coastwise Capital Group’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $445K | Sell |
3,520
-30
| -0.8% | -$3.8K | 0.35% | 64 |
|
2025
Q1 | $454K | Buy |
3,550
+2
| +0.1% | +$256 | 0.38% | 63 |
|
2024
Q4 | $469K | Sell |
3,548
-50
| -1% | -$6.61K | 0.37% | 66 |
|
2024
Q3 | $524K | Buy |
3,598
+3
| +0.1% | +$437 | 0.43% | 65 |
|
2024
Q2 | $494K | Sell |
3,595
-300
| -8% | -$41.2K | 0.47% | 57 |
|
2024
Q1 | $535K | Buy |
3,895
+1
| +0% | +$137 | 0.5% | 58 |
|
2023
Q4 | $529K | Sell |
3,894
-55
| -1% | -$7.47K | 0.54% | 51 |
|
2023
Q3 | $483K | Sell |
3,949
-300
| -7% | -$36.7K | 0.55% | 55 |
|
2023
Q2 | $539K | Hold |
4,249
| – | – | 0.61% | 47 |
|
2023
Q1 | $549K | Sell |
4,249
-799
| -16% | -$103K | 0.63% | 43 |
|
2022
Q4 | $663K | Buy |
5,048
+505
| +11% | +$66.3K | 0.79% | 34 |
|
2022
Q3 | $531K | Hold |
4,543
| – | – | 0.84% | 38 |
|
2022
Q2 | $534K | Buy |
4,543
+781
| +21% | +$91.8K | 0.65% | 45 |
|
2022
Q1 | $490K | Buy |
+3,762
| New | +$490K | 0.61% | 47 |
|